Skip to main content
. 2022 Sep 6;23(18):10256. doi: 10.3390/ijms231810256

Table 1.

Clinical and anthropometric parameters of T1D patients, siblings and CTRLs.

Parameter T1D
Average ± SD
Siblings
Average ± SD
CTRLs
Average ± SD
Birth weight (kg) 3.24 ± 0.55 3.02 ± 0.55 3.32 ± 0.42
BMI (kg/m2) 16.48 ± 2.84 19.88 ± 2.09 17.61 ± 1.61
Total Cholesterol (mg/dL) 155.65 ± 49.87 152.00 ± 14.76 153.98 ± 16.24
HDL-C (mg/dL) 42.44 ± 13.30 49.59 ± 3.12 50.39 ± 4.16
LDL-C (mg/dL) 95.70 ± 33.03 91.47 ± 3.12 94.81 ± 6.51
Triglycerides (mg/dL) 91.79 ± 45.65 60.47 ± 6.18 59.02 ± 6.32
Pubertal stage (PS) PS = 1 28 (53.8) 5 (29.4) 31 (54.4)
PS = 2–3 13 (25) 4 (23.5) 18 (31.6)
PS = 4–5 11 (21.2) 8 (47.1) 8 (14.0)
T1D Patients Features
Parameter Average ± SD Variable Cut Off Cases N (%)
Age at onset (years) 9.52 ± 3.21 Age at onset > 14 years 6 (11.5)
Blood pH at onset 7.26 ± 0.12 normal pH ≥ 7.32 24 (46.1)
moderate 7.10 ≤ pH < 7.32 24 (46.1)
severe pH < 7.10 4 (7.6)
Exogenous insulin need (IU/kg BM) 0.84 ± 0.25 Exogenous insulin need ≥1 IU/kg BM 15 (28.8)
IAA (U/mL) 6.38 ± 3.56 IAA ≥ 7 U/mL 18 (53.8)
IA-2 (U/mL) 40.56 ± 208.44 IA-2 > 1 U/mL 42 (80.8)
Anti-GAD (U/mL) 31.80 ± 40.91 Anti-GAD > 1 U/mL 31 (59.6)
c-peptide (ng/mL) 0.31 ± 0.19 c-peptide < 1 ng/mL 52 (100)
HbA1c (%) 102.37 ± 22.71 HbA1c > 48 mmol/mol 52 (100)
CRP (mg/L) 0.45 ± 1.40 CRP > 1 mg/L 4 (7.6)
Presence of other autoimmune diseases (i.e., Thyroiditis and celiac disease) 9 (17.3)

SD, standard deviation; BMI, body mass index; IAA, insulin autoantibodies; IA-2, islet antigen 2 antibody; anti-GAD, anti-glutamic acid decarboxylase antibody; HbA1c, glycated hemoglobin; HDL, High Density Lipoprotein Cholesterol; LDL, Low Density Lipoprotein Cholesterol; CRP, C-Reactive Protein.